Skip to main content
Carl Zeiss Meditec AG logo

Carl Zeiss Meditec AG — Investor Relations & Filings

Ticker · AFX ISIN · DE0005313704 LEI · 529900GRL4MZ8NMOOK95 F Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2026-05-28 Director's Dealing
Country DE Germany
Listing F AFX

About Carl Zeiss Meditec AG

https://www.zeiss.com/meditec-ag/en/hom…

Carl Zeiss Meditec AG is a leading global medical technology company with two strategic business units: Ophthalmology and Microsurgery. The Ophthalmology unit offers a comprehensive portfolio for the diagnosis and treatment of eye diseases, including diagnostic systems, surgical lasers, and intraocular lenses. The Microsurgery unit provides innovative visualization solutions, such as surgical microscopes, for medical disciplines including neurosurgery, spinal surgery, ENT, and dentistry. The company's technologies and application-oriented solutions are designed to help doctors improve the quality of life of their patients and advance medical progress.

Recent filings

Filing Released Lang Actions
Carl Zeiss Meditec AG: Peter Kameritsch, buy
Director's Dealing Classification · 94% confidence The document is a notification and public disclosure of an insider transaction by a member of the supervisory body (purchase of shares by Peter Kameritsch). This matches the definition for ‘Director’s Dealing’ (reports of personal share transactions by company directors and executives).
2026-05-28 English
Half-yearly financial report 2025/2026
Interim / Quarterly Report Classification · 98% confidence The document is titled “6-Month Report 2025/26” for Carl Zeiss Meditec Group and contains a full interim financial report: IFRS key performance indicators, consolidated management report, detailed consolidated financial statements (income statement, balance sheet, cash flow, notes) and related management discussion. It is not merely an announcement or a link to a report but the complete half-year report itself, fitting the definition of an Interim / Quarterly Report (IR). H1 2026
2026-05-27 English
AFX Launches Mainnet Points Program to Reward Real Traders, Liquidity Providers, and Communities
Regulatory Filings Classification · 55% confidence The document is a corporate press release announcing a product launch (Mainnet Points Program) rather than a financial report, governance document, or regulatory filing like an earnings release or annual report. It does not contain financial statements, meeting materials, or notice of corporate actions, but is general corporate news. This fits the fallback category for miscellaneous corporate/regulatory announcements (RNS).
2026-05-25 English
Appointment of new Chief Executive Officer of Carl Zeiss Meditec AG
Board/Management Information Classification · 91% confidence The document is an ad-hoc inside information announcement under EU MAR detailing the appointment of a new Chief Executive Officer, clearly relating to a change in the company’s executive management. It is not a full report but a personnel decision announcement. This matches the Board/Management Information category (MANG).
2026-05-22 English
Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution
Regulatory Filings Classification · 85% confidence The document is a statutory disclosure of related party transactions under Section 111c of the German Stock Corporation Act, clearly an announcement of compliance with regulatory requirements rather than a full financial report or other transaction type. It does not present detailed financial statements or annual/quarterly results, nor is it an earnings release, management change, or M&A filing. It best fits the fallback category for general regulatory announcements and compliance disclosures: Regulatory Filings (RNS).
2026-05-12 English
Carl Zeiss Meditec reports lower earnings in the first half of 2025/26 Comprehensive package of measures planned
Interim / Quarterly Report Classification · 98% confidence The document is a detailed half-year results announcement (“first half of fiscal year 2025/26”) featuring actual financial data (revenue, adjusted EBITA, segment tables by business unit and region), management commentary, outlook, and strategic measures. It is more than just headline earnings metrics (which would be an Earnings Release); it contains substantive financial tables and analysis for an interim period. This fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-05-12 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.